256 related articles for article (PubMed ID: 19228380)
1. Expression of Bmi-1 is a prognostic marker in bladder cancer.
Qin ZK; Yang JA; Ye YL; Zhang X; Xu LH; Zhou FJ; Han H; Liu ZW; Song LB; Zeng MS
BMC Cancer; 2009 Feb; 9():61. PubMed ID: 19228380
[TBL] [Abstract][Full Text] [Related]
2. [Expression and clinical significance of Bmi-1 protein in bladder cancer].
Qin ZK; Yang JA; Zeng MS; Zhou FJ; Han H; Liu ZW; Yu SL; Li YH; Chen ZF
Ai Zheng; 2008 Dec; 27(12):1327-30. PubMed ID: 19080003
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of EZH2, a polycomb group protein, in bladder carcinoma.
Arisan S; Buyuktuncer ED; Palavan-Unsal N; Caşkurlu T; Cakir OO; Ergenekon E
Urol Int; 2005; 75(3):252-7. PubMed ID: 16215315
[TBL] [Abstract][Full Text] [Related]
4. Expression level of Bmi-1 oncoprotein is associated with progression and prognosis in colon cancer.
Li DW; Tang HM; Fan JW; Yan DW; Zhou CZ; Li SX; Wang XL; Peng ZH
J Cancer Res Clin Oncol; 2010 Jul; 136(7):997-1006. PubMed ID: 20024662
[TBL] [Abstract][Full Text] [Related]
5. Expression of hedgehog pathway components is associated with bladder cancer progression and clinical outcome.
He HC; Chen JH; Chen XB; Qin GQ; Cai C; Liang YX; Han ZD; Dai QS; Chen YR; Zeng GH; Zhu JG; Jiang FN; Zhong WD
Pathol Oncol Res; 2012 Apr; 18(2):349-55. PubMed ID: 21861243
[TBL] [Abstract][Full Text] [Related]
6. Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer.
Gazzaniga P; Gradilone A; Giuliani L; Gandini O; Silvestri I; Nofroni I; Saccani G; Frati L; Aglianò AM
Ann Oncol; 2003 Jan; 14(1):85-90. PubMed ID: 12488298
[TBL] [Abstract][Full Text] [Related]
7. Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells.
Song LB; Zeng MS; Liao WT; Zhang L; Mo HY; Liu WL; Shao JY; Wu QL; Li MZ; Xia YF; Fu LW; Huang WL; Dimri GP; Band V; Zeng YX
Cancer Res; 2006 Jun; 66(12):6225-32. PubMed ID: 16778197
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of BMI1, a polycomb group repressor protein, in bladder tumors: a preliminary report.
Shafaroudi AM; Mowla SJ; Ziaee SA; Bahrami AR; Atlasi Y; Malakootian M
Urol J; 2008; 5(2):99-105. PubMed ID: 18592462
[TBL] [Abstract][Full Text] [Related]
9. Prostate stem cell antigen is overexpressed in human transitional cell carcinoma.
Amara N; Palapattu GS; Schrage M; Gu Z; Thomas GV; Dorey F; Said J; Reiter RE
Cancer Res; 2001 Jun; 61(12):4660-5. PubMed ID: 11406532
[TBL] [Abstract][Full Text] [Related]
10. Prognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinoma.
Liu WL; Guo XZ; Zhang LJ; Wang JY; Zhang G; Guan S; Chen YM; Kong QL; Xu LH; Li MZ; Song LB; Zeng MS
BMC Cancer; 2010 Sep; 10():467. PubMed ID: 20809956
[TBL] [Abstract][Full Text] [Related]
11. Expression parameters of the polycomb group proteins BMI1, SUZ12, RING1 and CBX7 in urothelial carcinoma of the bladder and their prognostic relevance.
Hinz S; Kempkensteffen C; Christoph F; Krause H; Schrader M; Schostak M; Miller K; Weikert S
Tumour Biol; 2008; 29(5):323-9. PubMed ID: 18984978
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological and prognostic significance of Bmi-1 expression in human cervical cancer.
Min L; Dong-Xiang S; Xiao-Tong G; Ting G; Xiao-Dong C
Acta Obstet Gynecol Scand; 2011 Jul; 90(7):737-45. PubMed ID: 21309753
[TBL] [Abstract][Full Text] [Related]
13. Expression and clinicopathological significance of Mel-18 and Bmi-1 mRNA in gastric carcinoma.
Lu YW; Li J; Guo WJ
J Exp Clin Cancer Res; 2010 Nov; 29(1):143. PubMed ID: 21059209
[TBL] [Abstract][Full Text] [Related]
14. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Henke C; Korabiowska M; Schlott T; Zimmerman B; Kunze E
Anticancer Res; 2004; 24(2B):1011-23. PubMed ID: 15161057
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of Sox2 expression in transurethral resection specimens in patients with T1 bladder cancer.
Ruan J; Wei B; Xu Z; Yang S; Zhou Y; Yu M; Liang J; Jin K; Huang X; Lu P; Cheng H
Med Oncol; 2013 Mar; 30(1):445. PubMed ID: 23307254
[TBL] [Abstract][Full Text] [Related]
16. Expression of BMI-1 and Mel-18 in breast tissue--a diagnostic marker in patients with breast cancer.
Riis ML; Lüders T; Nesbakken AJ; Vollan HS; Kristensen V; Bukholm IR
BMC Cancer; 2010 Dec; 10():686. PubMed ID: 21162745
[TBL] [Abstract][Full Text] [Related]
17. Expression and prognostic significance of survivin in the progression of bladder transitional cell cancer.
Wang Y; Zhu Z; Zeng F; Wang L; Wu Y; Xia W; Xing S
J Huazhong Univ Sci Technolog Med Sci; 2007 Aug; 27(4):444-7. PubMed ID: 17828507
[TBL] [Abstract][Full Text] [Related]
18. Bmi-1 expression predicts prognosis for patients with gastric carcinoma.
Liu JH; Song LB; Zhang X; Guo BH; Feng Y; Li XX; Liao WT; Zeng MS; Huang KH
J Surg Oncol; 2008 Mar; 97(3):267-72. PubMed ID: 18041745
[TBL] [Abstract][Full Text] [Related]
19. Expression of beclin 1 in bladder cancer and its clinical significance.
Liu GH; Zhong Q; Ye YL; Wang HB; Hu LJ; Qin ZK; Zeng MS; Zeng BH
Int J Biol Markers; 2013 Apr; 28(1):56-62. PubMed ID: 23125008
[TBL] [Abstract][Full Text] [Related]
20. Prohibitin in the pathogenesis of transitional cell bladder cancer.
Wu TF; Wu H; Wang YW; Chang TY; Chan SH; Lin YP; Liu HS; Chow NH
Anticancer Res; 2007; 27(2):895-900. PubMed ID: 17465217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
